Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Intersect ENT, Inc. (XENT) Class Action Lawsuit (May 2019)

Closed

4:19cv2647 • May 15, 2019

Class Period Start

February 27, 2018

Class Period End

October 30, 2019

PSLRA Deadline

July 15, 2019

Case Allegations

10b5

Statutes of Repose

Feb 27, 2021

Country

United States

Court

Federal Court

Settlement Information

Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.

Claim Deadline

November 18, 2021

Settlement Fund

$1,900,000

Settlement Status

Disbursed

Settlement Class

All persons or entities that purchased or otherwise acquired publicly traded Intersect ENT, Inc. (“Intersect”) common stock between February 27, 2018 and August 1, 2019, inclusive.

Claim Administrator

A.B. Data, Ltd.
Yaron v. Intersect ENT, Inc., et al. c/o A.B. Data, Ltd. P.O. Box 173131 Milwaukee, WI 53217
+1 877-777-9611
[email protected]

Settlement Website

-

Hearing Date

October 22, 2021

Opt-out Deadline

October 1, 2021

Settlement Note

Download here

Proof Of Claim

Download here

Docket History

Apr 10, 2023

Disbursement Approved

The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.

Nov 5, 2021

Final Approval of Settlement

The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.

Jul 21, 2021

Proof of Claim Form

To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.

Jun 22, 2021

Preliminary Approval of Settlement

The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.

May 14, 2021

Proposed Settlement

May 4, 2021

Scheduling Order

Feb 5, 2021

Scheduling Order

Jan 22, 2021

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Sep 18, 2020

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Jul 29, 2020

Second Amended Complaint

A new complaint has been filed on behalf of certain investors in Intersect ENT, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Jul 1, 2020

Scheduling Order

Jun 19, 2020

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Jan 31, 2020

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Dec 2, 2019

First Amended Complaint

A new complaint has been filed on behalf of certain investors in Intersect ENT, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Oct 8, 2019

Scheduling Order

Sep 24, 2019

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

May 15, 2019

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in Intersect ENT, Inc..

TOP